Skip to content

End-of-life distress: all studies

Page 33 of 40: studies 321 to 330 of 391, newest first. Back to the end-of-life distress overview

Research

Achtsamkeit, Selbstfürsorge und Mitgefühl. Entwicklung und Evaluation einer Fortbildung zur Integration von Achtsamkeits- und Mitgefühlspraktiken in den Arbeitsalltag von Krankenhausteams

Natallia Sender 2020 Orellana Rios

Eine wachsende Anzahl von Studien belegt, dass achtsamkeitsbasierte Programme sich als vorteilhaft in der Förderung der Resilienz und in der Reduktion von Belastung von Krankenhausmitarbeiter*innen erweisen. Bei den gängigen Achtsamkeitsprogrammen wird jedoch in der Regel nur wenig dafür getan, den Transfer des Erlernten in den Arbeitsalltag der Mitarbeiter*innen sicherzustellen. Außerdem wurde...

Utilidades terapéuticas del ayahuasca

Libro Comunicaciones 2020 R. Pinilla, Psicologa Clara Rodriguez, Diana Batet et al.

Objetivo: Exponer los potenciales beneficios terapéuticos del uso de ayahuasca, desde la neurofarmacología y la evidencia clínica existente hasta el momento. Material y métodos: Se realizó una revisión de la literatura en las bases de datos pubmed, clinical key y textos de difusión científica. Resultados y conclusiones: Existe literatura acerca del potencial uso terapéutico del ayahuasca en...

Bruno's Score.

Journal of Pain and Symptom Management September 1, 2019 Buddy Marterre

Many of our experiences in hospice and palliative care medicine are challenging. We support dying patients and their families as they struggle with the transition from life to death and continue to support those in mourning. Many times, in America, it is difficult to even appreciate a glimmer of spiritual grace as our patients die. We easily remain stuck in the material and distance ourselves...

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Pharmacology & Therapeutics May 1, 2019 Matthew W Johnson, Peter S. Hendricks, Frederick S. Barrett et al. 520 citations

The purpose of this paper is to provide an integrative review and offer novel insights regarding human research with classic psychedelics (classic hallucinogens), which are serotonin 2A receptor (5-HT2AR) agonists such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Classic psychedelics have been administered as sacraments since ancient times. They were of prominent interest...

An Internet-Based Compassion-Focused Intervention for Increased Self-Criticism: A Randomized Controlled Trial.

Behavior Therapy March 2019 Tobias Krieger, Fabienne Reber, Barbara Von Glutz et al.

Increased levels of self-criticism and a lack of self-compassion have been associated with the development and maintenance of a range of psychological disorders. In the current study, we tested the efficacy of an online version of a compassion-focused intervention, mindfulness-based compassionate living (MBCL), with guidance on request. A total of 122 self-referred participants with increased...

DOI: 10.1016/j.beth.2018.08.003 (opens in new tab) Full text (opens in new tab) Depression Compassion-focused Online intervention Randomized controlled trial +1

Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens

Journal of Psychedelic Studies February 25, 2019 Jenna Varley 4 citations

Psychedelics have been investigated for their therapeutic applications in end-of-life care as early as 1960. Recently, there have been four main groups conducting clinical trials for either lysergic acid diethylamide or psilocybin for the treatment of anxiety and depression in patients with terminal illnesses. The recent trials have higher methodological quality and demonstrate the profound...

DOI: 10.1556/2054.2019.005 (opens in new tab) Psilocybin Death anxiety Distress Psychotherapist +4

Transgender and the transpersonal: An introduction and a call for research

Transpersonal Psychology Review 2019 Scott Buckler, Jenni Gates

While there is a tradition of research in relation to the lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI+) community and religiosity, there is a paucity of research relating to spirituality. Additionally, classifying such ‘non–conforming’ groups into a general classification has inherent problems, specifically in relation to those identifying as transgender more likely to...

THE RECEPTION OF C.G. JUNG IN US DEATH AND DYING STUDIES

Phanês Journal For Jung History November 19, 2018 Jelena Martinovic 1 citation

C.G. Jung’s work has had a noticeable impact on conceptions about death and the dying experience, as well as on the therapeutic work methods that deal with anxiety, depression or terminal illnesses. This article analyses the reception of C.G. Jung’s work in the United States during the time period 1960-80. It examines ways in which Jung’s concepts were discussed and applied by psy practitioners...

DOI: 10.32724/phanes.2018.martinovic (opens in new tab) Mysticism Thanatology Psychoanalysis Transpersonal psychology +10

Tua o te Aria. Doorways into Dying

Ata: Journal of Psychotherapy Aotearoa New Zealand September 24, 2018 Kay Ryan

As we age or become terminally ill, we are confronted by our mortality. Being confronted by our own or another’s death can be a time of accelerated and profound growth and development. Using examples from research and personal experience working in a hospice, this article explores challenges facing our own dying as well as that of clients and family members. It discusses the relevance and...

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

International Review of Psychiatry July 4, 2018 Stephen Ross 103 citations

Cancer is highly prevalent and one of the leading causes of global morbidity and mortality. Psychological and existential suffering is common in cancer patients, associated with poor psychiatric and medical outcomes. Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related...